Physician

Jeffrey L Halaas, MD

According to 2025 Medicare claims, Jeffrey Halaas, MD (NPI: 1851346928) practices hematology/oncology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is OPTUM MEDICAL CARE, P.C. (NPI: 1982643003; TIN: 133544120) and primary practice location at 10509-9998. Halaas is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Halaas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 674 traditional Medicare patients, billed 147,167 HCPCS/CPT codes, and received $1,950,874 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,702 prescription claims across 275 beneficiaries totaling $5,645,941 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,109,853 to $5,645,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2015 Medicare payment: $2,133,324 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,121,396 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,528,957 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,217,688 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,455,009 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,027,902 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,808,482 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,096,019 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,117,051 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,950,874 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015683207,547$2,133,324
2016688175,700$2,121,396
2017714201,779$2,528,957
2018651157,218$2,217,688
2019705188,644$2,455,009
2020658183,747$3,027,902
2021618175,600$2,808,482
2022720215,181$3,096,019
2023700203,789$3,117,051
2024674147,167$1,950,874

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.8M$5.6M2015 Drug cost: $2,109,853 (USD; Tot_Drug_Cst)2016 Drug cost: $2,364,177 (USD; Tot_Drug_Cst)2017 Drug cost: $2,720,184 (USD; Tot_Drug_Cst)2018 Drug cost: $3,705,167 (USD; Tot_Drug_Cst)2019 Drug cost: $3,836,400 (USD; Tot_Drug_Cst)2020 Drug cost: $4,831,057 (USD; Tot_Drug_Cst)2021 Drug cost: $5,440,977 (USD; Tot_Drug_Cst)2022 Drug cost: $5,218,448 (USD; Tot_Drug_Cst)2023 Drug cost: $5,038,876 (USD; Tot_Drug_Cst)2024 Drug cost: $5,645,941 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151961,220$2,109,853
20161881,198$2,364,177
20172181,532$2,720,184
20182081,413$3,705,167
20192491,552$3,836,400
20202591,744$4,831,057
20212661,768$5,440,977
20222641,567$5,218,448
20232621,635$5,038,876
20242751,702$5,645,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$32K2015 Medicare payment: $32,180 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $19,590 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $8,202 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,312 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $9,673 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $524 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R57$32,180
2016N/R48$19,590
2017N/R25$8,202
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R31$2,777
2021N/RN/RN/R
2022N/R32$1,312
2023N/R58$9,673
2024N/R11$524

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3561,079$105
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's311651$14
80053Blood test, comprehensive group of blood chemicals248846$10
36415Insertion of needle into vein for collection of blood sample4271,557$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3761,287$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib772,310$1,121,269
ImbruvicaIbrutinib531,508$868,967
XtandiEnzalutamide361,080$494,049
JakafiRuxolitinib Phosphate28840$485,568
PomalystPomalidomide19532$442,593

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R11$524

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Jeffrey L. Halaas, MD?

Tedicare shows public-source Medicare data for Jeffrey L. Halaas, MD (NPI 1851346928), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey L. Halaas, MD have ACO affiliation data?

Jeffrey L. Halaas, MD is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Jeffrey L. Halaas, MD?

Jeffrey L. Halaas, MD is linked to OPTUM MEDICAL CARE, P.C. (billing NPI 1982643003) in the available physician profile data.

Does Jeffrey L. Halaas, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.